14
total announcements
540145.BO · 15 min delayed
Valiant Organics Ltd
Valiant Organics Ltd announces the newspaper publication of the pre-dispatch of notice for its 21st Annual General Meeting, scheduled to be held on September 29, 2026, through Video Conferencing/Other Audio Visual Means.
Valiant Organics Ltd
Valiant Organics Ltd has announced its Q1-FY27 earnings presentation, highlighting its diversified client base, manufacturing units, and production capacity. The company has a strong presence in the chlorophenol derivatives market and is one of the largest domestic manufacturers of ortho anisidine and para anisidine. Valiant Organics has a market capitalization of INR ~ 7,545.68 Mn as on 30th June 2026.
Valiant Organics Ltd
Valiant Organics Ltd has published its financial results for the quarter ended June 30, 2026, and has also issued a notice to shareholders regarding the transfer of unclaimed dividend to the Investor Education Protection Fund (IEPF).
Valiant Organics Ltd
Valiant Organics Ltd has published its unaudited financial results for the quarter ended June 30, 2026, and has also notified shareholders about the transfer of unclaimed dividend to the Investor Education Protection Fund (IEPF).
Valiant Organics Ltd
Valiant Organics Ltd has granted 18,000 employee stock options to an eligible employee at an exercise price of Rs. 10 per option, subject to SEBI regulations.
Valiant Organics Ltd
Valiant Organics Ltd has announced the shifting of its Corporate Office to 701-A, Tower-B, Embassy 247 Park, Gandhi Nagar, Vikhroli (West), Mumbai – 400083, Maharashtra, from August 12, 2026. The company has also announced the re-appointment of Shri Sathiababu K. Kallada as the Managing Director for a term of 3 years, subject to shareholder approval.
Valiant Organics Ltd
Valiant Organics Ltd has announced a change in its registered office address, subject to shareholder approval, and reappointment of its Managing Director, Sathiababu K. Kallada, for a term of 3 years. The company has also published its unaudited standalone financial results for the quarter ended June 30, 2026.
Valiant Organics Ltd
Valiant Organics Ltd has announced the re-appointment of Sathiababu K. Kallada as Managing Director for a term of 3 years, subject to shareholder approval. The company has also announced its unaudited standalone financial results for the quarter ended June 30, 2026, and has shifted its registered office to a new location.
Valiant Organics Ltd
Valiant Organics Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also re-appointed Sathiababu K. Kallada as Managing Director for a term of 3 years. The company has also shifted its registered office and corporate office to new locations.
Valiant Organics Ltd
Valiant Organics Ltd has approved its unaudited financial results for the quarter ended June 30, 2026, and other matters, including the re-appointment of its Managing Director and the shifting of its Registered Office.
Valiant Organics Ltd
Valiant Organics Ltd has scheduled a Board Meeting on August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Valiant Organics Ltd
Valiant Organics Ltd has announced that CRISIL Ratings Limited has reaffirmed the credit ratings assigned to the company's bank facilities, with a revised outlook from 'Negative' to 'Stable'. The long-term rating remains at Crisil A-/ Stable, while the short-term rating is Crisil A2+.
Valiant Organics Ltd
Valiant Organics Ltd has received a reaffirmation of its credit ratings from CRISIL Ratings Limited, with a revised outlook from 'Negative' to 'Stable'. The company's long-term rating has been reaffirmed at 'Crisil A-', while the short-term rating remains 'Crisil A2+'.
Valiant Organics Ltd
Valiant Organics Ltd announced the allotment of 15,000 equity shares of face value Rs. 10 each to an eligible employee under its 'Valiant - Employees Stock Option Plan- 2022'. This issuance increases the company's paid-up equity share capital from 2,80,19,610 shares to 2,80,34,610 shares. The newly allotted shares rank pari-passu with existing equity shares.